KoMethylNet: An Innovative Epigenetic Clock Utilizing Neural Network Analysis of DNA Methylation and Age Acceleration in a Korean Cohort - Scorecard - MDSpire

KoMethylNet: An Innovative Epigenetic Clock Utilizing Neural Network Analysis of DNA Methylation and Age Acceleration in a Korean Cohort

  • By

  • Dabin Yun

  • Kwangyeon Oh

  • Yujin Kim

  • Yong Min Ahn

  • Hemang M. Parikh

  • Xiaoxi Meng

  • Zhaoming Wang

  • Nan Song

  • December 3, 2025

  • 0 min

Share

Clinical Scorecard: KoMethylNet: An Innovative Epigenetic Clock Utilizing Neural Network Analysis of DNA Methylation and Age Acceleration in a Korean Cohort

At a Glance

CategoryDetail
Condition
Key MechanismsInclude specific methodologies used in the DNA methylation analysis.
Target Population
Care Setting

Key Highlights

  • additional_info

Guideline-Based Recommendations

Diagnosis

    Management

    • S
    • p
    • e
    • c
    • i
    • f
    • y
    • i
    • n
    • t
    • e
    • r
    • v
    • e
    • n
    • t
    • i
    • o
    • n
    • s
    • b
    • a
    • s
    • e
    • d
    • o
    • n
    • E
    • A
    • A
    • f
    • i
    • n
    • d
    • i
    • n
    • g
    • s
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Clinical Best Practices

        • examples

        References

        Original Source(s)

        KoMethylNet: An Innovative Epigenetic Clock Utilizing Neural Network Analysis of DNA Methylation and Age Acceleration in a Korean Cohort

        • by Dabin Yun, Kwangyeon Oh, Yujin Kim, Yong Min Ahn, Hemang M. Parikh, Xiaoxi Meng, Zhaoming Wang, Nan Song

        • December 3, 2025

        Related Content

        Beyond the tumor: the role of the gut microbiome in triple-negative breast cancer

        Successful management of metachronous dual primary esophageal carcinomas: first report of consecutive adenoid cystic carcinoma and squamous cell carcinoma with exceptional treatment outcome—a case report

        Editorial: Innovative organoid co-culture systems for enhanced precision medicine in cancer and beyond